Revitalist Lifestyle and Wellness Ltd. Stock Canadian Securities Exchange

Stocks

CALM

CA76151T1030

Healthcare Facilities & Services

OTC Markets Traded
Delayed Canadian Securities Exchange 5-day change 1st Jan Change
- CAD -.--% Intraday chart for Revitalist Lifestyle and Wellness Ltd. -.--% -

Valuation: Revitalist Lifestyle and Wellness Ltd.

Market Cap 2.97M 2.6M 2.4M 2.25M 4.21M 280M 4.3M 28.83M 11.16M 138M 11.14M 10.9M 480M P/E 2021
-0.83x
P/E 2022 -0.12x
Enterprise Value 12.77M 11.2M 10.32M 9.66M 18.12M 1.2B 18.5M 124M 48.01M 595M 47.96M 46.91M 2.06B EV / Sales 2021
6,424,266x
EV / Sales 2022 369,034x
Free-Float
98.18%
Yield 2021 *
-
Yield 2022 -
5 years 0
Extreme 0
0.88
10 years 0
Extreme 0
0.88
Manager TitleAgeSince
Chief Operating Officer - 2023-03-29
Sales & Marketing - -
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 137
+0.14%+3.40%+53.71%+49.95% 134B
+1.33%+3.73%+3.55%+32.62% 85.84B
-0.72%+0.53%-5.62%+60.95% 25.72B
+1.04%+7.85%+17.91%+47.66% 22.83B
-0.09%-1.97%-18.15%-25.30% 19.93B
+0.56%+3.38%+7.09%+135.04% 15.84B
+1.44%+3.78%-1.44%+5.57% 14.65B
-0.02%+2.11%+51.75%+120.55% 13.7B
-0.07%+0.39%-14.96%-7.30% 12.5B
Average +0.37%+3.08%+10.43%+46.64% 38.28B
Weighted average by Cap. +0.46%+4.25%+23.20%+44.71%

Financials

2021 2022
Net sales 2.07 1.81 1.67 1.56 2.93 195.03 2.99 20.08 7.77 96.39 7.76 7.59 334.23 4.57 4 3.69 3.45 6.48 430.64 6.61 44.35 17.16 212.83 17.14 16.77 738
Net income -12.61M -11.06M -10.19M -9.54M -17.89M -1.19B -18.26M -122M -47.4M -588M -47.35M -46.31M -2.04B -13.63M -11.95M -11.02M -10.31M -19.34M -1.29B -19.74M -132M -51.23M -635M -51.18M -50.06M -2.2B
Net Debt 1.6 1.4 1.29 1.21 2.27 150.8 2.32 15.53 6.01 74.53 6 5.87 258.43 9.8 8.6 7.92 7.42 13.91 924.87 14.2 95.24 36.85 457.09 36.82 36.01 1.58K
Logo Revitalist Lifestyle and Wellness Ltd.
Revitalist Lifestyle and Wellness Ltd. is a mental health and wellness company focused on comprehensive care in the ketamine wellness space. The Company, through its Tennessee subsidiary, Revitalist LLC, operates physical locations in three states, virtual offices across six states and medical and behavioral services in two countries. The Company’s segments include Clinical Operations and Research. The Clinical Operations segment encompasses the Company’s ketamine assisted psychotherapy clinics across the United States. The Research segment consists of the development of virtual clinics in the metaverse and research focused expenses. The Company offers various therapies, such as Ketamine Therapy, Home Ketamine Therapy, Ketamine Assisted Psychotherapy, Spravato, Vitamin Therapy, Neuropeptide Therapy and Supplements. It offers treatment for various conditions, including Anxiety, Depression, PTSD, OCD, Bipolar Disorder, Pain, Suicidal Ideation and Substance Abuse.
Employees
-